CoVID-19: Parent and Caregiver Concerns About Reopening New Zealand Schools
Overview
Authors
Affiliations
Aim: Children generally have a milder CoVID-19 disease course and better prognosis than adults. Many countries have closed schools as part of measures to limit transmission and this has had a considerable impact on children world-wide. This includes New Zealand (NZ), where rates of CoVID-19 have been very low. The aims of this study were to investigate parents' and caregivers' knowledge of CoVID-19 in children, to understand their levels of concern and to identify their most trusted sources of information.
Methods: Participants were recruited via NZ parenting support and interest groups on Facebook.com. Knowledge was assessed by way of a self-administered questionnaire during the 10 days prior to NZ schools reopening on 18 May 2020.
Results: Of the 1191 study participants, 721 (60%) expressed some level of worry (14.5% very or extremely worried) that their child would catch CoVID-19 at school. A high proportion (79%, 941) thought it likely or very likely that their child would catch CoVID-19 at school if there were to be widespread community transmission. Fear scores for CoVID-19 were generally high, and 828 (80%) of participants said they would vaccinate their child if a newly developed vaccine were available.
Conclusions: Parents and caregivers were generally fearful of their children acquiring CoVID-19 at school. This was despite messaging from multiple trusted sources that transmission in schools is unlikely, and the number of NZ CoVID-19 cases being extremely low. These findings have implications for policy development and public health messaging both in NZ and in countries with ongoing community transmission of CoVID-19.
Maamor N, Muhamad N, Mohd Dali N, Leman F, Rosli I, Tengku Bahrudin Shah T PLoS One. 2024; 19(10):e0302379.
PMID: 39446774 PMC: 11500859. DOI: 10.1371/journal.pone.0302379.
Unveiling parental perspectives: COVID-19 vaccination for children in India.
Bhardwaj P, Yadav S, Jetly S, Saluja D, Taneja J J Family Med Prim Care. 2024; 13(4):1481-1487.
PMID: 38827713 PMC: 11142018. DOI: 10.4103/jfmpc.jfmpc_1485_23.
Rajamoorthy Y, Wagner A, Kumaran V, Munusamy S, Taib N, Tin O Narra J. 2024; 3(3):e187.
PMID: 38450341 PMC: 10914040. DOI: 10.52225/narra.v3i3.187.
Scudder J, DeBeck D Vaccines (Basel). 2024; 12(1).
PMID: 38250860 PMC: 10820387. DOI: 10.3390/vaccines12010047.
Zhang J, Smith J, Browne D Front Public Health. 2023; 11:1047234.
PMID: 37457258 PMC: 10341151. DOI: 10.3389/fpubh.2023.1047234.